UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial

The lancet oncology, 2013-04, Vol.14 (4), p.335-345

2013

Volltextzugriff (PDF)

Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials)

Current Oncology Reports, 2016-06, Vol.18 (6), p.37-37, Article 37

2016

Volltextzugriff (PDF)

TMPRSS2:ERG Gene Fusion Predicts Subsequent Detection of Prostate Cancer in Patients With High-Grade Prostatic Intraepithelial Neoplasia

Journal of clinical oncology, 2014-01, Vol.32 (3), p.206-211

2014

Volltextzugriff (PDF)

The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial

Journal of cachexia, sarcopenia and muscle, 2011-09, Vol.2 (3), p.153-161

2011

Volltextzugriff (PDF)

Phenotypic Characterization of Toxic Compound Effects on Liver Spheroids Derived from iPSC Using Confocal Imaging and Three-Dimensional Image Analysis

Assay and drug development technologies, 2016-09, Vol.14 (7), p.381-394

2016

Volltextzugriff (PDF)

Prostate Cancer Diagnosis Among Men With Isolated High-Grade Intraepithelial Neoplasia Enrolled Onto a 3-Year Prospective Phase III Clinical Trial of Oral Toremifene

Journal of clinical oncology, 2013-02, Vol.31 (5), p.523-529

2013

Volltextzugriff (PDF)

Hormone levels following surgical and medical castration: defining optimal androgen suppression

Asian journal of andrology, 2018-07, Vol.20 (4), p.405-406

2018

Volltextzugriff (PDF)

Hepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expression

The Journal of pharmacology and experimental therapeutics, 2003-12, Vol.307 (3), p.906-922

2003

Volltextzugriff (PDF)

Toremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

The Journal of urology, 2010-10, Vol.184 (4), p.1316-1321

2010

Volltextzugriff (PDF)

Phenotypic Assays for Characterizing Compound Effects on Induced Pluripotent Stem Cell-Derived Cardiac Spheroids

Assay and drug development technologies, 2017-08, Vol.15 (6), p.280-296

2017

Volltextzugriff (PDF)

Selective androgen receptor modulators for the treatment of late onset male hypogonadism

Asian journal of andrology, 2014-03, Vol.16 (2), p.256-261

2014

Volltextzugriff (PDF)

Hydroperiods of Cypress Domes in West-Central Florida, USA

Wetlands (Wilmington, N.C.), 2020-12, Vol.40 (6), p.2225-2234

2020

Volltextzugriff (PDF)

Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia

Blood, 2000-10, Vol.96 (8), p.2691-2696

2000

Volltextzugriff (PDF)

Negative regulators of insulin signaling revealed in a genome-wide functional screen

PloS one, 2009-09, Vol.4 (9), p.e6871-e6871

2009

Volltextzugriff (PDF)

P-type lectins

BBA - General Subjects, 2002-09, Vol.1572 (2), p.317-340

2002

Volltextzugriff (PDF)

A quantitative TR-FRET plate reader immunoassay for measuring autophagy

Autophagy, 2012-08, Vol.8 (8), p.1227-1244

2012

Volltextzugriff (PDF)

Toremifene Decreases Vertebral Fractures in Men Younger Than 80 Years Receiving Androgen Deprivation Therapy for Prostate Cancer

The Journal of urology, 2011-12, Vol.186 (6), p.2239-2244

2011

Volltextzugriff (PDF)

Phase 2 Trial of GTx-758, an Estrogen Receptor Alpha Agonist, in Men With Castration-Resistant Prostate Cancer

Clinical genitourinary cancer, 2020-12, Vol.18 (6), p.436-443

2020

Volltextzugriff (PDF)

Toremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

The Journal of urology, 2013, Vol.189 (1), p.S45-S50

2013

Volltextzugriff (PDF)

ExoY, an Adenylate Cyclase Secreted by the Pseudomonas aeruginosa Type III System

Proceedings of the National Academy of Sciences - PNAS, 1998-11, Vol.95 (23), p.13899-13904

1998

Volltextzugriff (PDF)

A Facile Method for Simultaneously Measuring Neuronal Cell Viability and Neurite Outgrowth

Current chemical genomics and translational medicine, 2015, Vol.9 (1), p.6-16

2015

Volltextzugriff (PDF)

Selective Estrogen Receptor Alpha Agonist GTx-758 Decreases Testosterone with Reduced Side Effects of Androgen Deprivation Therapy in Men with Advanced Prostate Cancer

European urology, 2015-02, Vol.67 (2), p.334-341

2015

Volltextzugriff (PDF)

Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report

Neuro-oncology (Charlottesville, Va.), 2007-04, Vol.9 (2), p.145

2007

Volltextzugriff (PDF)

Factors Associated With Vertebral Fractures in Men Treated With Androgen Deprivation Therapy for Prostate Cancer

The Journal of urology, 2011-08, Vol.186 (2), p.482-486

2011

Volltextzugriff (PDF)

Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia

Blood, 2002-07, Vol.100 (1), p.52-58

2002

Volltextzugriff (PDF)

1 – 25 von 1.544

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.295)
Mit Volltextzugriff
(1.236)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.542)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial

Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials)

TMPRSS2:ERG Gene Fusion Predicts Subsequent Detection of Prostate Cancer in Patients With High-Grade Prostatic Intraepithelial Neoplasia

The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial

Phenotypic Characterization of Toxic Compound Effects on Liver Spheroids Derived from iPSC Using Confocal Imaging and Three-Dimensional Image Analysis

Prostate Cancer Diagnosis Among Men With Isolated High-Grade Intraepithelial Neoplasia Enrolled Onto a 3-Year Prospective Phase III Clinical Trial of Oral Toremifene

Hormone levels following surgical and medical castration: defining optimal androgen suppression

Hepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expression

Toremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

Phenotypic Assays for Characterizing Compound Effects on Induced Pluripotent Stem Cell-Derived Cardiac Spheroids

Selective androgen receptor modulators for the treatment of late onset male hypogonadism

Hydroperiods of Cypress Domes in West-Central Florida, USA

Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia

Negative regulators of insulin signaling revealed in a genome-wide functional screen

P-type lectins

A quantitative TR-FRET plate reader immunoassay for measuring autophagy

Toremifene Decreases Vertebral Fractures in Men Younger Than 80 Years Receiving Androgen Deprivation Therapy for Prostate Cancer

Phase 2 Trial of GTx-758, an Estrogen Receptor Alpha Agonist, in Men With Castration-Resistant Prostate Cancer

Toremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

ExoY, an Adenylate Cyclase Secreted by the Pseudomonas aeruginosa Type III System

A Facile Method for Simultaneously Measuring Neuronal Cell Viability and Neurite Outgrowth

Selective Estrogen Receptor Alpha Agonist GTx-758 Decreases Testosterone with Reduced Side Effects of Androgen Deprivation Therapy in Men with Advanced Prostate Cancer

Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report

Factors Associated With Vertebral Fractures in Men Treated With Androgen Deprivation Therapy for Prostate Cancer

Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia

Suchergebnisse filtern